documents: FDA-2026-N-3446-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-3446-0001 FDA FDA-2026-N-3446 Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) Notice Notice of Approval 2026-04-16T04:00:00Z 2026 4     2026-04-16T18:19:33Z 2026-07368 0 0 09000064b9286565

Links from other tables